BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3497437)

  • 1. Diphtheria in vaccinated persons.
    Rabo E
    Scand J Infect Dis; 1987; 19(3):383-4. PubMed ID: 3497437
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological effectiveness of a 2d revaccination against diphtheria performed at intervals extended up to 7-10 years].
    Maksimova NM; Sukhorukova NL; Finkel' MP
    Zh Mikrobiol Epidemiol Immunobiol; 1987 May; (5):50-4. PubMed ID: 3497501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The epidemic process of diphtheria and pertussis with active immunization of a pediatric population].
    Blinova LL
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Nov; (11):30-1. PubMed ID: 2879404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of the Lf content of diphtheria toxoid as a guide to its immunogenic value in DPT vaccine.
    Habbu MK; Poonawalla CS; Parvatikar MS; Jadhav SS
    Indian Pediatr; 1987 Feb; 24(2):141-4. PubMed ID: 3499394
    [No Abstract]   [Full Text] [Related]  

  • 5. Acellular pertussis vaccines.
    Hinman AR; Onorato IM
    Pediatr Infect Dis J; 1987 Apr; 6(4):341-3. PubMed ID: 3495774
    [No Abstract]   [Full Text] [Related]  

  • 6. Circulating immune complexes after DTP immunization.
    Habig WH; Holohan TV; Phillips TM
    J Pediatr; 1988 Jan; 112(1):162-3. PubMed ID: 3257263
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunity and immunization of children against diphtheria in Sweden.
    Mark A; Christenson B; Granström M; Strandell A; Wickbom B; Böttiger M
    Eur J Clin Microbiol Infect Dis; 1989 Mar; 8(3):214-9. PubMed ID: 2496989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibody response to the fractionated administration of the 2d or 3d basic vaccination injection with a mixed vaccine against diphtheria, tetanus and pertussis].
    Vodicková M; Svandová E
    Cesk Pediatr; 1986 Jun; 41(6):321-3. PubMed ID: 2872973
    [No Abstract]   [Full Text] [Related]  

  • 9. Diphtheria, tetanus, pertussis: antibody detection in New Zealand.
    Lau RC
    N Z Med J; 1987 Aug; 100(829):481-3. PubMed ID: 3502676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative immunologic effectiveness of variants of the DTP vaccine].
    Baeva EA; Selezneva TS; Rezepov FF; Chebotareva SV; El'nitskaia EA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Oct; (10):50-2. PubMed ID: 2879402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractional doses of DPT vaccine.
    Wassilak S; Brink EW
    CMAJ; 1985 Oct; 133(7):642. PubMed ID: 3876148
    [No Abstract]   [Full Text] [Related]  

  • 12. Acellular pertussis vaccine: immunogenicity and safety of an acellular pertussis vs. a whole cell pertussis vaccine combined with diphtheria and tetanus toxoids as a booster in 18- to 24-month old children.
    Pichichero ME; Badgett JT; Rodgers GC; McLinn S; Trevino-Scatterday B; Nelson JD
    Pediatr Infect Dis J; 1987 Apr; 6(4):352-63. PubMed ID: 3495775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunological effectiveness of secondary revaccination against tetanus performed at prolonged intervals].
    Maksimova NM; Basova NN; Sukhorukova NL; Finkel' MP
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jun; (6):43-6. PubMed ID: 3307239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response to measles vaccine with DTPP.
    John TJ; Selvakumar R; Balrai V; Simoes EA
    Am J Dis Child; 1987 Jan; 141(1):14. PubMed ID: 3491536
    [No Abstract]   [Full Text] [Related]  

  • 15. Pediatric diphtheria and tetanus toxoids-adsorbed vaccine: immune response to the first booster following the diphtheria and tetanus toxoids vaccine primary series.
    Pichichero ME; Barkin RM; Samuelson JS
    Pediatr Infect Dis; 1986; 5(4):428-30. PubMed ID: 3487779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Need for new strategies for an old, persistent disease.
    St Geme JW; Barraff LJ
    J Pediatr; 1985 Aug; 107(2):245-6. PubMed ID: 3874944
    [No Abstract]   [Full Text] [Related]  

  • 17. What is 'significant' and DTP reactions.
    Pediatrics; 1988 Jun; 81(6):912-3. PubMed ID: 3259310
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intracutaneous test with tetanus toxoid--a possibility for evaluating cellular immune reaction].
    Schöntube M; Thilo W; Schmitz HH
    Padiatr Grenzgeb; 1986; 25(2-3):275-81. PubMed ID: 3487763
    [No Abstract]   [Full Text] [Related]  

  • 19. Age and dose interval as factors in agglutinin formation to pertussis vaccine.
    Wilkins J; Chan LS; Wehrle PF
    Vaccine; 1987 Mar; 5(1):49-54. PubMed ID: 2883784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody level of New Zealand children immunized with the triple vaccine DTP (diphtheria-tetanus-pertussis).
    Lau RC
    Epidemiol Infect; 1988 Oct; 101(2):405-10. PubMed ID: 2903065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.